Kazuki Matsui

Title: Kazuki Matsui: Innovator in Pharmaceutical Chemistry

Introduction

Kazuki Matsui is a notable inventor based in Sanda, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the human body. With a total of 4 patents to his name, Matsui's work has the potential to impact the treatment of various medical conditions.

Latest Patents

One of Matsui's latest patents involves a quinazolinone derivative. This compound is described as an optically active form of quinazolinone derivatives, which has a selective antagonism for the M3 muscarinic receptor. It also exhibits a depressant action on the frequency of rhythmic bladder contractions, making it useful for treating pollakiuria and urinary incontinence. Another significant patent pertains to Rho kinase inhibitors, which are represented by a specific formula indicating the presence of 1 to 4 R-X groups that may be the same or different.

Career Highlights

Throughout his career, Kazuki Matsui has worked with prominent companies in the pharmaceutical industry. He has been associated with Dainippon Sumitomo Pharma Co., Ltd. and Sumitomo Pharmaceuticals Company Limited. His work in these organizations has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Matsui has collaborated with several talented individuals in his field, including Naohito Ohashi and Masami Muraoka. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Kazuki Matsui is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important medical compounds. His contributions, reflected in his patents, demonstrate his commitment to improving healthcare solutions.